FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W183222764> ?p ?o ?g. }

• W183222764 abstract "Lung cancer has the highest morbidity and mortality of any malignant tumor. To improve efficacy and reduce toxicity in patients with advanced non-small cell lung cancer (NSCLC), it is important to integrate traditional and conventional medicine. Two hundred and forty patients with advanced NSCLC were randomized to tetrandrine plus GP or GP only. We infused gemcitabine on days 1 and 8; cisplatin on day 1. The tetrandrine group received continuous i.v. infusion for 10 days, with treatment repeated every 21 days. After 2 consecutive treatment cycles, we used RECIST criteria to evaluate short-term efficacy. Quality of life (QOL) was assessed according to Karnofsky score (KPS) and body weight change. We used NCI CTC 3.0 to evaluate treatment toxicity. The short-term objective response rate was 36.1% in the tetrandrine group and 24.3% in the controls (P=0.057). The short-term disease control rate was 63.9% in the tetrandrine group and 52.3% in the controls (P=0.081). The 1-year survival rates were 45.7% and 31.3%, respectively (P=0.059). KPS scores improved by 49.1% and 32.4%, respectively (P=0.012). Body weight increased by 28.7% in the tetrandrine group and 16.2% in the controls (P=0.027). The incidence of grade 2-4 leukopenia, thrombocytopenia, nausea, and vomiting in the tetrandrine group was 38.0%, 19.4%, 46.3%, and 16.7%, respectively; the control group figures were 53.2%, 34.2%, 63.0% and 27.9% (P<0.05). Tetrandrine may improve short-term efficacy and survival in patients with advanced NSCLC. Tetrandrine may also mitigate adverse reactions to chemotherapy and improve QOL for patients with NSCLC." @default.
• W183222764 created "2016-06-24" @default.
• W183222764 creator A5010074837 @default.
• W183222764 creator A5010299185 @default.
• W183222764 creator A5014048532 @default.
• W183222764 creator A5022634072 @default.
• W183222764 creator A5039737834 @default.
• W183222764 creator A5053951421 @default.
• W183222764 creator A5057704753 @default.
• W183222764 creator A5060080037 @default.
• W183222764 creator A5060550983 @default.
• W183222764 creator A5085616638 @default.
• W183222764 date "2012-03-01" @default.
• W183222764 modified "2023-10-06" @default.
• W183222764 title "Tetrandrine combined with gemcitabine and Cisplatin for patients with advanced non-small cell lung cancer improve efficacy." @default.
• W183222764 cites W1810174015 @default.
• W183222764 cites W1972237278 @default.
• W183222764 cites W1978583401 @default.
• W183222764 cites W1992028431 @default.
• W183222764 cites W2015259841 @default.
• W183222764 cites W2019607817 @default.
• W183222764 cites W2020830322 @default.
• W183222764 cites W2044573147 @default.
• W183222764 cites W2048446768 @default.
• W183222764 cites W2049396815 @default.
• W183222764 cites W2050809217 @default.
• W183222764 cites W2063845423 @default.
• W183222764 cites W2092145777 @default.
• W183222764 cites W2106787323 @default.
• W183222764 cites W2140561713 @default.
• W183222764 cites W2147188402 @default.
• W183222764 cites W2168636998 @default.
• W183222764 cites W2169436143 @default.
• W183222764 cites W2245476761 @default.
• W183222764 cites W2275052674 @default.
• W183222764 cites W2319059842 @default.
• W183222764 cites W2375147852 @default.
• W183222764 cites W2390093342 @default.
• W183222764 cites W24035434 @default.
• W183222764 cites W2504684570 @default.
• W183222764 cites W2965641343 @default.
• W183222764 cites W2993686169 @default.
• W183222764 cites W3145077989 @default.
• W183222764 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3614858" @default.
• W183222764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23675254" @default.
• W183222764 hasPublicationYear "2012" @default.
• W183222764 type Work @default.
• W183222764 sameAs 183222764 @default.
• W183222764 citedByCount "6" @default.
• W183222764 countsByYear W1832227642015 @default.
• W183222764 countsByYear W1832227642017 @default.
• W183222764 countsByYear W1832227642020 @default.
• W183222764 countsByYear W1832227642022 @default.
• W183222764 crossrefType "journal-article" @default.
• W183222764 hasAuthorship W183222764A5010074837 @default.
• W183222764 hasAuthorship W183222764A5010299185 @default.
• W183222764 hasAuthorship W183222764A5014048532 @default.
• W183222764 hasAuthorship W183222764A5022634072 @default.
• W183222764 hasAuthorship W183222764A5039737834 @default.
• W183222764 hasAuthorship W183222764A5053951421 @default.
• W183222764 hasAuthorship W183222764A5057704753 @default.
• W183222764 hasAuthorship W183222764A5060080037 @default.
• W183222764 hasAuthorship W183222764A5060550983 @default.
• W183222764 hasAuthorship W183222764A5085616638 @default.
• W183222764 hasConcept C121608353 @default.
• W183222764 hasConcept C126322002 @default.
• W183222764 hasConcept C2776256026 @default.
• W183222764 hasConcept C2776694085 @default.
• W183222764 hasConcept C2778239845 @default.
• W183222764 hasConcept C2779934757 @default.
• W183222764 hasConcept C2780258809 @default.
• W183222764 hasConcept C2780580376 @default.
• W183222764 hasConcept C2780852908 @default.
• W183222764 hasConcept C29730261 @default.
• W183222764 hasConcept C71924100 @default.
• W183222764 hasConcept C90924648 @default.
• W183222764 hasConcept C98274493 @default.
• W183222764 hasConceptScore W183222764C121608353 @default.
• W183222764 hasConceptScore W183222764C126322002 @default.
• W183222764 hasConceptScore W183222764C2776256026 @default.
• W183222764 hasConceptScore W183222764C2776694085 @default.
• W183222764 hasConceptScore W183222764C2778239845 @default.
• W183222764 hasConceptScore W183222764C2779934757 @default.
• W183222764 hasConceptScore W183222764C2780258809 @default.
• W183222764 hasConceptScore W183222764C2780580376 @default.
• W183222764 hasConceptScore W183222764C2780852908 @default.
• W183222764 hasConceptScore W183222764C29730261 @default.
• W183222764 hasConceptScore W183222764C71924100 @default.
• W183222764 hasConceptScore W183222764C90924648 @default.
• W183222764 hasConceptScore W183222764C98274493 @default.
• W183222764 hasLocation W1832227641 @default.
• W183222764 hasOpenAccess W183222764 @default.
• W183222764 hasPrimaryLocation W1832227641 @default.
• W183222764 hasRelatedWork W1426247572 @default.
• W183222764 hasRelatedWork W1978583401 @default.
• W183222764 hasRelatedWork W2011761515 @default.
• W183222764 hasRelatedWork W2114882308 @default.
• W183222764 hasRelatedWork W2120977451 @default.
• W183222764 hasRelatedWork W2147188402 @default.
• W183222764 hasRelatedWork W2167888501 @default.

• next